{"url":"https://lda.gov/api/v1/filings/36a2b07a-264e-44d9-a3c1-849e41cbf899/","filing_uuid":"36a2b07a-264e-44d9-a3c1-849e41cbf899","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2025,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/36a2b07a-264e-44d9-a3c1-849e41cbf899/print/","filing_document_content_type":"text/html","income":"20000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Edward Long, PhD, Vice President","dt_posted":"2025-04-18T10:07:06-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"800 Maine Avenue, SW","registrant_address_2":"Suite 800","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20024","registrant":{"id":39837,"url":"https://lda.gov/api/v1/registrants/39837/","house_registrant_id":32802,"name":"VAN SCOYOC ASSOCIATES","description":"Government Relations Consultant","address_1":"800 Maine Avenue, SW","address_2":"Suite 800","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20024","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"H. STEWART VAN SCOYOC","contact_telephone":"+1 202-638-1950","dt_updated":"2026-07-30T13:26:38.045563-04:00"},"client":{"id":148272,"url":"https://lda.gov/api/v1/clients/148272/","client_id":1005573,"name":"COLLEGE ON PROBLEMS OF DRUG DEPENDENCE","general_description":"Professional organization addressing problems of drug dependence and drug addiction.","client_government_entity":false,"client_self_select":false,"state":"VA","state_display":"Virginia","country":"US","country_display":"United States of America","ppb_state":null,"ppb_state_display":null,"ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2009-01-08"},"lobbying_activities":[{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"H.R.9029/S.4942, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2025, Provisions relating to NIH, substance use research indirect costs Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2026, Provisions relating to NIH, substance use research and indirect costs","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":54690,"prefix":null,"prefix_display":null,"first_name":"EDWARD","nickname":null,"middle_name":null,"last_name":"LONG","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":46253,"prefix":null,"prefix_display":null,"first_name":"KATHERINE","nickname":null,"middle_name":null,"last_name":"VANLANDINGHAM","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"H.R.9029/S.4942, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2025, Provisions relating to NIH, substance use research indirect costs Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2026, Provisions relating to NIH, substance use research and indirect costs H.R.1802, Safeguard Pets, Animals, and Research Ethics (SPARE) Act , Entirety H.R.27/S.331, HALT Fentanyl Act, Drug use research related issues Synthetic Fentanyl related issues Barriers to research resulting from DEA scheduling, Drug research related issues Monitor Support for Patients and Communities Reauthorization Act, Xylazine related issues Monitor Contingency Management, Protocol related issues","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":54690,"prefix":null,"prefix_display":null,"first_name":"EDWARD","nickname":null,"middle_name":null,"last_name":"LONG","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":46253,"prefix":null,"prefix_display":null,"first_name":"KATHERINE","nickname":null,"middle_name":null,"last_name":"VANLANDINGHAM","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}